RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.66M | -10.00M | -11.13M | -12.11M | -6.54M |
| Total Depreciation and Amortization | 640.40K | 754.20K | 826.40K | 887.30K | 848.20K |
| Total Amortization of Deferred Charges | 900.00 | 500.00 | 100.00 | -300.00 | -- |
| Total Other Non-Cash Items | 6.15M | 6.04M | 6.60M | 7.20M | 2.28M |
| Change in Net Operating Assets | 1.72M | 1.40M | 1.47M | 1.08M | -63.60K |
| Cash from Operations | -1.14M | -1.81M | -2.24M | -2.94M | -3.47M |
| Capital Expenditure | -16.00K | -25.10K | -42.80K | -34.80K | -57.40K |
| Sale of Property, Plant, and Equipment | 593.10K | 556.40K | -- | -- | 103.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00K | -10.60K | -41.50K | 300.00 | 27.10K |
| Cash from Investing | 572.10K | 520.70K | -84.20K | -34.40K | 72.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -214.20K | -255.30K | -264.80K | -258.10K | -265.10K |
| Issuance of Common Stock | -- | -- | -- | -- | 1.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.40K | 16.20K | 0.00 | 0.00 | 8.50K |
| Cash from Financing | -141.50K | -171.80K | -192.30K | -189.70K | -187.80K |
| Foreign Exchange rate Adjustments | -7.70K | -3.90K | 21.10K | 500.00 | 20.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -714.20K | -1.46M | -2.49M | -3.16M | -3.57M |